Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cassader

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Atherosclerosis|June 1, 1988
Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patientsG Niort, A Bulgarelli, M Cassader, et al.
Journal of Lipid Mediators and Cell Signalling|April 3, 1998
Characterization and representative structures of N-oligosaccharides bound to apolipoprotein HR Gambino, G Ruiu, G Pagano, et al.
Journal of Protein Chemistry|May 20, 1999
Apolipoprotein H is not affected by in vitro glycosylationR Gambino, G Ruiu, G Pagano, et al.
Journal of Lipid Research|April 1, 1996
Apolipoprotein H: a two-step isolation methodR Gambino, G Ruiu, M Cassader, et al.
Journal of Lipid Mediators and Cell Signalling|May 1, 1997
Characterization of the carbohydrate structures of apolipoprotein H through concanavalin A affinity chromatographyR Gambino, G Ruiu, G Pagano, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1993
Bezafibrate affects lipid, lipo- and apolipoprotein pattern in non-insulin-dependent diabetic patientsG Niort, R Gambino, M Cassader, et al.
Diabetologia|January 27, 2012
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trialsG Musso, M Cassader, F Rosina, et al.
La Clinica Terapeutica|August 31, 1987
[Changes in carbohydrate and lipid metabolism in chronic renal insufficiency]M Cassader, G Ruiu, A R Leoncavallo, et al.
Archives of Internal Medicine|April 1, 1987
Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabeticsA Bruno, P Cavallo-Perin, M Cassader, et al.
The International Journal of Artificial Organs|July 1, 1989
Lipoprotein and apoprotein levels in different types of dialysisM Cassader, G Ruiu, V Tagliaferro, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Atherosclerosis|June 1, 1988
Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patientsG Niort, A Bulgarelli, M Cassader, et al.
Journal of Lipid Mediators and Cell Signalling|April 3, 1998
Characterization and representative structures of N-oligosaccharides bound to apolipoprotein HR Gambino, G Ruiu, G Pagano, et al.
Journal of Protein Chemistry|May 20, 1999
Apolipoprotein H is not affected by in vitro glycosylationR Gambino, G Ruiu, G Pagano, et al.
Journal of Lipid Research|April 1, 1996
Apolipoprotein H: a two-step isolation methodR Gambino, G Ruiu, M Cassader, et al.
Journal of Lipid Mediators and Cell Signalling|May 1, 1997
Characterization of the carbohydrate structures of apolipoprotein H through concanavalin A affinity chromatographyR Gambino, G Ruiu, G Pagano, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1993
Bezafibrate affects lipid, lipo- and apolipoprotein pattern in non-insulin-dependent diabetic patientsG Niort, R Gambino, M Cassader, et al.
Diabetologia|January 27, 2012
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trialsG Musso, M Cassader, F Rosina, et al.
La Clinica Terapeutica|August 31, 1987
[Changes in carbohydrate and lipid metabolism in chronic renal insufficiency]M Cassader, G Ruiu, A R Leoncavallo, et al.
Archives of Internal Medicine|April 1, 1987
Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabeticsA Bruno, P Cavallo-Perin, M Cassader, et al.
The International Journal of Artificial Organs|July 1, 1989
Lipoprotein and apoprotein levels in different types of dialysisM Cassader, G Ruiu, V Tagliaferro, et al.
Pageof 10